Danisco Nutrition And Biosciences India Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 06-11-2024
- Paid Up Capital ₹ 9.01 Cr
as on 06-11-2024
- Company Age 4 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 13383449.52%
(FY 2023)
- Profit 6792503.18%
(FY 2023)
- Ebitda 16616623.88%
(FY 2023)
- Net Worth 13111053.57%
(FY 2023)
- Total Assets 7957387.91%
(FY 2023)
About Danisco Nutrition And Biosciences India
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 9.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
Savindu Kudrigikar and Sheril Vaidhyan serve as directors at the Company.
- CIN/LLPIN
U74999DL2020FTC360903
- Company No.
360903
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
27 Jan 2020
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
East Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Danisco Nutrition And Biosciences India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sheril Vaidhyan  | Director | 15-Jan-2021 | Current |
| Savindu Kudrigikar | Director | 15-Jan-2021 | Current |
Financial Performance and Corporate Structure Insights of Danisco Nutrition And Biosciences India.
Danisco Nutrition And Biosciences India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13383449.52% increase. The company also saw a substantial improvement in profitability, with a 6792503.18% increase in profit. The company's net worth Soared by an impressive increase of 13111053.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Danisco Nutrition And Biosciences India?
In 2023, Danisco Nutrition And Biosciences India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Danisco Nutrition And Biosciences India?
Danisco Nutrition And Biosciences India has a workforce of 14 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Danisco Nutrition And Biosciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Danisco Nutrition And Biosciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
